Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Akili, Inc.

AKLINASDAQ
Healthcare
Medical - Healthcare Information Services
$0.43
$0.001(0.25%)
U.S. Market opens in 14h 25m

Akili, Inc. Fundamental Analysis

Akili, Inc. (AKLI) shows weak financial fundamentals with a PE ratio of -0.57, profit margin of -35.45%, and ROE of -70.32%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position222.80%
PEG Ratio-0.01
Current Ratio6.02

Areas of Concern

ROE-70.32%
Operating Margin-38.43%
We analyze AKLI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3379.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3379.0/100

We analyze AKLI's fundamental strength across five key dimensions:

Efficiency Score

Weak

AKLI struggles to generate sufficient returns from assets.

ROA > 10%
-74.01%

Valuation Score

Excellent

AKLI trades at attractive valuation levels.

PE < 25
-0.57
PEG Ratio < 2
-0.01

Growth Score

Weak

AKLI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

AKLI maintains a strong and stable balance sheet.

Debt/Equity < 1
0.26
Current Ratio > 1
6.02

Profitability Score

Weak

AKLI struggles to sustain strong margins.

ROE > 15%
-7031.81%
Net Margin ≥ 15%
-35.45%
Positive Free Cash Flow
No

Key Financial Metrics

Is AKLI Expensive or Cheap?

P/E Ratio

AKLI trades at -0.57 times earnings. This suggests potential undervaluation.

-0.57

PEG Ratio

When adjusting for growth, AKLI's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Akili, Inc. at 0.58 times its book value. This may indicate undervaluation.

0.58

EV/EBITDA

Enterprise value stands at -1.66 times EBITDA. This is generally considered low.

-1.66

How Well Does AKLI Make Money?

Net Profit Margin

For every $100 in sales, Akili, Inc. keeps $-35.45 as profit after all expenses.

-35.45%

Operating Margin

Core operations generate -38.43 in profit for every $100 in revenue, before interest and taxes.

-38.43%

ROE

Management delivers $-70.32 in profit for every $100 of shareholder equity.

-70.32%

ROA

Akili, Inc. generates $-74.01 in profit for every $100 in assets, demonstrating efficient asset deployment.

-74.01%

Following the Money - Real Cash Generation

Operating Cash Flow

Akili, Inc. generates limited operating cash flow of $-58.26M, signaling weaker underlying cash strength.

$-58.26M

Free Cash Flow

Akili, Inc. generates weak or negative free cash flow of $-58.40M, restricting financial flexibility.

$-58.40M

FCF Per Share

Each share generates $-0.74 in free cash annually.

$-0.74

FCF Yield

AKLI converts -1.70% of its market value into free cash.

-1.70%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.57

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.58

vs 25 benchmark

P/S Ratio

Price to sales ratio

20.32

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.26

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.02

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.70

vs 25 benchmark

ROA

Return on assets percentage

-0.74

vs 25 benchmark

ROCE

Return on capital employed

-0.96

vs 25 benchmark

How AKLI Stacks Against Its Sector Peers

MetricAKLI ValueSector AveragePerformance
P/E Ratio-0.5729.28 Better (Cheaper)
ROE-70.32%820.00% Weak
Net Margin-3545.47%-19743.00% (disorted) Weak
Debt/Equity0.260.26 Neutral
Current Ratio6.024.69 Strong Liquidity
ROA-74.01%-17807.00% (disorted) Weak

AKLI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Akili, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ